Hoggard N, Green C D
Mol Cell Endocrinol. 1986 Jun;46(1):71-8. doi: 10.1016/0303-7207(86)90071-7.
The growth of ZR-75-1 cells, a line of human breast cancer cells in culture, is stimulated by oestradiol and inhibited by anti-oestrogens. Changes in growth rate caused by these agents are accompanied by changes in activity of ornithine decarboxylase, a rate-limiting enzyme for polyamine synthesis. Furthermore, the growth inhibition caused by tamoxifen, an anti-oestrogen, can be reversed by the addition of spermine, spermidine or putrescine to the cells. Insulin can also stimulate ZR-75-1 cell growth and this is again accompanied by an increase in ODC activity. The reduced cell growth rate observed when the cells become confluent is associated with a marked decrease in ornithine decarboxylase activity. Experiments performed with DFMO, a specific and irreversible inhibitor of ODC, show that this compound can prevent the stimulation of growth by oestradiol and that this may be overcome by the addition of putrescine to the cells. It would appear that increased ODC activity and polyamine synthesis are necessary components of the stimulation of breast cancer cell growth by oestradiol but that other growth regulatory stimuli also may act via this enzyme.
ZR-75-1细胞系是一种培养的人乳腺癌细胞系,其生长受雌二醇刺激,受抗雌激素抑制。这些物质引起的生长速率变化伴随着鸟氨酸脱羧酶活性的变化,鸟氨酸脱羧酶是多胺合成的限速酶。此外,抗雌激素他莫昔芬引起的生长抑制可通过向细胞中添加精胺、亚精胺或腐胺来逆转。胰岛素也能刺激ZR-75-1细胞生长,这同样伴随着鸟氨酸脱羧酶活性的增加。当细胞汇合时观察到的细胞生长速率降低与鸟氨酸脱羧酶活性的显著降低有关。用鸟氨酸脱羧酶的特异性不可逆抑制剂DFMO进行的实验表明,该化合物可阻止雌二醇对生长的刺激,而向细胞中添加腐胺可克服这种抑制。看来,鸟氨酸脱羧酶活性增加和多胺合成是雌二醇刺激乳腺癌细胞生长的必要组成部分,但其他生长调节刺激也可能通过该酶起作用。